1vyd: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:1vyd.gif|left|200px]]
{{Seed}}
[[Image:1vyd.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1vyd|  PDB=1vyd  |  SCENE=  }}  
{{STRUCTURE_1vyd|  PDB=1vyd  |  SCENE=  }}  


'''CRYSTAL STRUCTURE OF CYTOCHROME C2 MUTANT G95E'''
===CRYSTAL STRUCTURE OF CYTOCHROME C2 MUTANT G95E===




==Overview==
<!--  
All class I c-type cytochromes studied to date undergo a dynamic process in the oxidized state, which results in the transient breaking of the iron-methionine-sulfur bond and sufficient movement to allow the binding of exogenous ligands (imidazole in this work). In the case of Rhodobacter capsulatus cytochrome c(2), the sixth heme ligand Met96 and up to 14 flanking residues (positions 88-100, termed the hinge region), located between two relatively rigid helical regions, may be involved in structural changes leading to a transient high-spin species able to bind ligands. We have examined 14 mutations at 9 positions in the hinge region of Rhodobacter capsulatus cytochrome c(2) and have determined the structure of the G95E mutant. Mutations near the N- and C-terminus of the hinge region do not affect the kinetics of movement but allow us to further define that portion of the hinge that moves away from the heme to the 93-100 region in the amino acid sequence. Mutations at positions 93 and 95 can alter the rate constant for hinge movement (up to 20-fold), presumably as a result of altering the structure of the native cytochrome to favor a more open conformation. The structure of one of these mutants, G95E, suggests that interactions within the hinge region are stabilized while interaction between the hinge and the heme are destabilized. In contrast, mutations at positions 98 and 99 alter imidazole binding kinetics but not the hinge movement. Thus, it appears that these mutations affect the structure of the cytochrome after the hinge region has moved away from the heme, resulting in increased solvent access to the bound imidazole or alter interactions between the protein and the bound imidazole.
The line below this paragraph, {{ABSTRACT_PUBMED_15196014}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 15196014 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_15196014}}


==About this Structure==
==About this Structure==
Line 33: Line 37:
[[Category: Mutant]]
[[Category: Mutant]]
[[Category: Redox]]
[[Category: Redox]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 12:54:38 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 10:00:39 2008''

Revision as of 10:00, 29 July 2008

File:1vyd.png

Template:STRUCTURE 1vyd

CRYSTAL STRUCTURE OF CYTOCHROME C2 MUTANT G95ECRYSTAL STRUCTURE OF CYTOCHROME C2 MUTANT G95E

Template:ABSTRACT PUBMED 15196014

About this StructureAbout this Structure

1VYD is a Single protein structure of sequence from Rhodobacter capsulatus. Full crystallographic information is available from OCA.

ReferenceReference

Protein dynamics in the region of the sixth ligand methionine revealed by studies of imidazole binding to Rhodobacter capsulatus cytochrome c2 hinge mutants., Dumortier C, Fitch J, Van Petegem F, Vermeulen W, Meyer TE, Van Beeumen JJ, Cusanovich MA, Biochemistry. 2004 Jun 22;43(24):7717-24. PMID:15196014

Page seeded by OCA on Tue Jul 29 10:00:39 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA